Real-world evaluation of multimodal treatment practice in older oesophageal cancer patients

医学 模式治疗法 癌症 新辅助治疗 内科学 队列 逻辑回归 化疗 放化疗 外科 肿瘤科 乳腺癌
作者
Tianzheng Shen,Yajie Zhang,Yuqin Cao,Jie Zhang,Hecheng Li
出处
期刊:European Journal of Cardio-Thoracic Surgery [Oxford University Press]
标识
DOI:10.1093/ejcts/ezae329
摘要

Abstract OBJECTIVES Elderly-specific data for multimodal treatment of oesophageal cancer (EC) is lacking. This study aimed to evaluate the safety and efficacy of multimodal treatment in older EC patients and to compare the impact of neoadjuvant chemotherapy (NCT) and neoadjuvant chemoradiotherapy (NCRT). METHODS Patients diagnosed with oesophageal squamous cell carcinoma or adenocarcinoma who received NCT/NCRT were identified in the National Cancer Database (NCDB, 2004–2015). First, we compared baseline and post-treatment characteristics between younger (<70 years) and older patients (≥70 years). Logistic regression was used to investigate risk factors of postoperative mortality. Second, we evaluated the effect of neoadjuvant chemotherapy on postoperative mortality and overall survival in the older cohort. Inverse probability of treatment weights (IPTW) and multivariable analyses were used to compensate for differences in baseline covariates. RESULTS We first compared outcomes of neoadjuvant therapy plus oesophagectomy in 14778 eligible EC patients. The older group experienced higher rates of postoperative mortality at 30 days (5.8%) and 90 days (13.5%) compared to younger patients. Postoperative mortality was significantly related to the Charlson-Deyo score and treatment-related factors including NAT type and minimally invasive technique. Second, among the 3,141 older patients (with a median follow-up of 57.8 months and 2029 deaths), those receiving NCT obtained significantly lower postoperative mortality and improved overall survival compared with NCRT (IPTW-Adjusted P = 0.05; HR, 0.85; 95% Cl, 0.72–0.99). CONCLUSIONS Neoadjuvant therapy plus oesophagectomy carries increased short-term mortality risk in older EC patients. NCT in older EC patients showed lower postoperative mortality but no statistically significant differences in overall survival with a point estimate favoring NCT compared to the NCRT group, making NCT a potential option for consideration in specific cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
永不言弃完成签到 ,获得积分10
1秒前
可爱天川完成签到,获得积分10
1秒前
俞孤风发布了新的文献求助200
2秒前
蔫蔫完成签到,获得积分10
3秒前
糖糖完成签到 ,获得积分10
3秒前
kekeke科完成签到,获得积分10
3秒前
AoGuo完成签到,获得积分10
3秒前
3秒前
小李给我支棱起来完成签到,获得积分10
4秒前
David完成签到 ,获得积分10
5秒前
浅沫juanjuan完成签到 ,获得积分10
5秒前
长安完成签到,获得积分10
5秒前
rice0601完成签到,获得积分10
5秒前
粥可温完成签到,获得积分10
5秒前
K_GRAPES完成签到,获得积分10
6秒前
阿坤完成签到,获得积分10
6秒前
8秒前
沙力VAN完成签到,获得积分10
8秒前
kong发布了新的文献求助10
8秒前
728完成签到,获得积分10
8秒前
8秒前
Sera完成签到,获得积分10
9秒前
小城故事和冰雨完成签到,获得积分10
9秒前
ASXC给ASXC的求助进行了留言
9秒前
ld2024完成签到,获得积分10
11秒前
健壮的涑完成签到 ,获得积分10
11秒前
杨晓白完成签到,获得积分10
11秒前
13秒前
金刚大王完成签到,获得积分10
13秒前
Xl完成签到,获得积分10
14秒前
14秒前
想跟这个世界讲个道理完成签到,获得积分10
15秒前
铜离子发布了新的文献求助10
15秒前
CodeCraft应助黄启烽采纳,获得10
15秒前
16秒前
清嘉完成签到,获得积分10
16秒前
yn完成签到,获得积分10
17秒前
儒雅南风完成签到 ,获得积分10
17秒前
结实的栾完成签到,获得积分10
17秒前
无为完成签到 ,获得积分10
18秒前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
A new approach to the extrapolation of accelerated life test data 500
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3953555
求助须知:如何正确求助?哪些是违规求助? 3499137
关于积分的说明 11094114
捐赠科研通 3229679
什么是DOI,文献DOI怎么找? 1785728
邀请新用户注册赠送积分活动 869490
科研通“疑难数据库(出版商)”最低求助积分说明 801478